New facility at the existing facility in Milford, MA, USA will significantly expand cGMP manufacturing capabilities and accelerate the clinical and commercial supply of vital biopharmaceuticals
New facility at the existing facility in Milford, MA, USA will significantly expand cGMP manufacturing capabilities and accelerate the clinical and commercial supply of vital biopharmaceuticals
Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, is opening the Ecolab Healthcare Advanced Design Center in Eagan, Minn.
As new and novel drug therapies are developed to address areas where conventional medicines are limited, drug delivery innovators, designers and manufacturers have turned to Picocyl for its unique, patented power solutions for drug and implant delivery systems.
Shire plc, the global biotechnology leader in rare diseases, announced today that the United States Food and Drug Administration (FDA) has approved the company’s first submission for its new plasma manufacturing facility near Covington, Georgia for the production of GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency (PI).
Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities.
Merck KGaA, Darmstadt, Germany today announced today announced moves designed to pave the way for an even more successful future in China. Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced today announced moves designed to pave the way for an even more successful future in China.
Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO), further reinforcing Novacap’s capabilities and offering for the pharmaceutical industry.
MIT engineers have developed a probiotic mix of natural and engineered a probiotic bacteria to diagnose and treat cholera, an intestinal infection that causes severe dehydration. Cholera outbreaks are usually caused by contaminated drinking water, and infections can turn fatal if not treated.
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced the publication of a study in Scientific Reports, a Nature Publishing Group journal, describing the development of the CubiCAR, an all-in-one Chime
E06 Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease. Study uncovers new potential therapeutic approach for a number of diseases linked to inflammation, including atherosclerosis, aortic stenosis and hepatic steatosis
10 Easy steps to cleaning a contaminated surface in the biosafety cabinet. The biosafety cabinet is a laboratory workspace that ensures safety and cleanliness for both the person operating in the cleanroom as well as the products or materials being handled in the cleanroom. The biosafety cabinet creates a safe environment for working with drugs, chemicals or hazardous materials.
The feeding systems are a key part of the new continuous production concept. At Pfizer, the compact arrangement of pharmaceutical feeders supplied by Coperion K-Tron accurately deliver ingredients into the continuous mixing process, thereby guaranteeing consistent and very high quality end products.